Near term catalysts for Geron are: patent court clearance, partner offers that follow, updates on FDA trials and GERN trading near cash value of $120 million. GERN is way oversold here.
Remember you can lose all your money in any stock.
Good luck in this rigged casino,
No comments:
Post a Comment